News Summary: Alzheimer's drug fails in a study

News Summary: Alzheimer's drug fails in a study

News Summary: Alzheimer's drug fails in a study

Print
Email
|

Associated Press

Posted on July 23, 2012 at 8:02 PM

Updated Tuesday, Jul 24 at 2:00 AM

DISAPPOINTING DATA: In the latest setback in Alzheimer's research, an experimental drug failed the first of four late-stage studies. The treatment didn't slow mental or functional decline in patients with mild or moderate Alzheimer's who carry a gene that increases the risk of the disease.

WHAT'S NEXT: Development partners Pfizer Inc. and Johnson & Johnson will continue three other late-stage tests of bapineuzumab. Two studies are in patients who don't have the ApoE4 gene.

WHAT'S AT STAKE: There's no treatment that does more than temporarily ease Alzheimer's symptoms, which afflict about 5 million Americans.

Print
Email
|